Mona Ashiya

Mona Ashiya is a Partner at OrbiMed Advisors LLC (“OrbiMed”) where she has been involved in a number of private and public company investments. Prior to joining OrbiMed in 2010, Mona covered the biotechnology industry as a member of J.P. Morgan’s biotechnology equity research team. Her previous experience includes positions at the Global Alliance for Tuberculosis Drug Development and the Harvard Business School. She earned a B.A. degree from the University of California at Berkeley, a Ph.D. in Cellular, Molecular, and Developmental Biology from the University of Pittsburgh, and was a post-doctoral fellow at the Dana Farber Cancer Institute.